What VASO ACTIVE PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Anderson Robert Edward | Director | Feb 24 | Open-market buy · P | +1,000 | $26.28 | +$26.3K | 36,000 |
| Masiz John J | Director | Feb 23 | Other Transaction · J | +3,000,000 | — | — | 4,500,000 |
| Anderson Robert Edward | Director | Feb 23 | Open-market buy · P | +200 | $28.50 | +$5.7K | 33,000 |
| Anderson Robert Edward | Director | Feb 23 | Open-market buy · P | +800 | $28.55 | +$22.8K | 32,400 |
| Anderson Robert Edward | Director | Jan 21 | Open-market buy · P | +200 | $7.29 | +$1.46K | 10,000 |
| Anderson Robert Edward | Director | Jan 21 | Open-market buy · P | +3,000 | $7.23 | +$21.7K | 9,800 |
| Anderson Robert Edward | Director | Jan 21 | Open-market buy · P | +2,000 | $7.15 | +$14.3K | 6,800 |
| Anderson Robert Edward | Director | Jan 21 | Open-market buy · P | +1,800 | $7.12 | +$12.8K | 4,800 |
| Anderson Robert Edward | Director | Jan 21 | Open-market buy · P | +1,000 | $7.00 | +$7K | 3,000 |
| Anderson Robert Edward | Director | Jan 20 | Open-market buy · P | +2,000 | $6.60 | +$13.2K | 2,000 |
| Strasnick Brian | Director | Dec 15 | Derivative Conversion · C | +21,411 | $2.50 | +$53.5K | 21,411 |
Loading...
